A systematic review of circulating IP-10/CXCL10 in patients with Plasmodium infections in relation to disease severity

Abstract Interferon γ-induced protein 10 kDa (IP-10) or C–X–C motif chemokine 10 (CXCL10) is produced and secreted from specific leukocytes such as neutrophils, eosinophils, and monocytes, which play key roles in the immune response to Plasmodium infections. This systematic review aimed to collate a...

Full description

Saved in:
Bibliographic Details
Main Authors: Manas Kotepui, Aongart Mahittikorn, Frederick Ramirez Masangkay, Kwuntida Uthaisar Kotepui
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-82712-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559551584763904
author Manas Kotepui
Aongart Mahittikorn
Frederick Ramirez Masangkay
Kwuntida Uthaisar Kotepui
author_facet Manas Kotepui
Aongart Mahittikorn
Frederick Ramirez Masangkay
Kwuntida Uthaisar Kotepui
author_sort Manas Kotepui
collection DOAJ
description Abstract Interferon γ-induced protein 10 kDa (IP-10) or C–X–C motif chemokine 10 (CXCL10) is produced and secreted from specific leukocytes such as neutrophils, eosinophils, and monocytes, which play key roles in the immune response to Plasmodium infections. This systematic review aimed to collate and critically appraise the current evidence on IP-10 levels in malaria patients. It provided insights into its role in malaria pathogenesis and potential as a biomarker for Plasmodium infections and disease severity. The protocol for this systematic review was registered in PROSPERO (number CRD42024556087). A comprehensive literature search was conducted across multiple databases, including Embase, PubMed, Scopus, Ovid, ProQuest, and MEDLINE, to identify relevant studies examining the role of IP-10 in patients with Plasmodium infections. A narrative synthesis was applied to summarize key findings and to provide an overview of the relationship between IP-10/CXCL10 levels and Plasmodium infection and disease severity. A total of 1933 records were identified, and 26 studies were included in the synthesis. The studies collectively indicated that IP-10 levels are elevated in patients with Plasmodium infections compared to healthy or non-malarial controls. Most studies reported that increased IP-10 levels were associated with increased disease severity. However, a few studies found no significant difference or decreased levels in patients with severe Plasmodium infections compared to those with uncomplicated or mild malaria. Additionally, several studies indicated that IP-10 levels were elevated in cerebral malaria. The systematic review suggests that IP-10 is elevated in patients with Plasmodium infections. However, the variability in findings across different studies regarding the association between IP-10 and severe malaria, particularly cerebral malaria, highlights the need for further comprehensive studies. Addressing confounding factors will be crucial in future research to better understand the role of IP-10 in Plasmodium infections and the pathogenesis of severe disease.
format Article
id doaj-art-d16ff7a1b8e64dc3b24aaf5a31dcc150
institution Kabale University
issn 2045-2322
language English
publishDate 2024-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-d16ff7a1b8e64dc3b24aaf5a31dcc1502025-01-05T12:23:58ZengNature PortfolioScientific Reports2045-23222024-12-0114111210.1038/s41598-024-82712-0A systematic review of circulating IP-10/CXCL10 in patients with Plasmodium infections in relation to disease severityManas Kotepui0Aongart Mahittikorn1Frederick Ramirez Masangkay2Kwuntida Uthaisar Kotepui3Medical Technology Program, Faculty of Science, Nakhon Phanom UniversityDepartment of Protozoology, Faculty of Tropical Medicine, Mahidol UniversityDepartment of Medical Technology, Faculty of Pharmacy, University of Santo TomasMedical Technology Program, Faculty of Science, Nakhon Phanom UniversityAbstract Interferon γ-induced protein 10 kDa (IP-10) or C–X–C motif chemokine 10 (CXCL10) is produced and secreted from specific leukocytes such as neutrophils, eosinophils, and monocytes, which play key roles in the immune response to Plasmodium infections. This systematic review aimed to collate and critically appraise the current evidence on IP-10 levels in malaria patients. It provided insights into its role in malaria pathogenesis and potential as a biomarker for Plasmodium infections and disease severity. The protocol for this systematic review was registered in PROSPERO (number CRD42024556087). A comprehensive literature search was conducted across multiple databases, including Embase, PubMed, Scopus, Ovid, ProQuest, and MEDLINE, to identify relevant studies examining the role of IP-10 in patients with Plasmodium infections. A narrative synthesis was applied to summarize key findings and to provide an overview of the relationship between IP-10/CXCL10 levels and Plasmodium infection and disease severity. A total of 1933 records were identified, and 26 studies were included in the synthesis. The studies collectively indicated that IP-10 levels are elevated in patients with Plasmodium infections compared to healthy or non-malarial controls. Most studies reported that increased IP-10 levels were associated with increased disease severity. However, a few studies found no significant difference or decreased levels in patients with severe Plasmodium infections compared to those with uncomplicated or mild malaria. Additionally, several studies indicated that IP-10 levels were elevated in cerebral malaria. The systematic review suggests that IP-10 is elevated in patients with Plasmodium infections. However, the variability in findings across different studies regarding the association between IP-10 and severe malaria, particularly cerebral malaria, highlights the need for further comprehensive studies. Addressing confounding factors will be crucial in future research to better understand the role of IP-10 in Plasmodium infections and the pathogenesis of severe disease.https://doi.org/10.1038/s41598-024-82712-0PlasmodiumMalariaIP-10CXCL10Systematic review
spellingShingle Manas Kotepui
Aongart Mahittikorn
Frederick Ramirez Masangkay
Kwuntida Uthaisar Kotepui
A systematic review of circulating IP-10/CXCL10 in patients with Plasmodium infections in relation to disease severity
Scientific Reports
Plasmodium
Malaria
IP-10
CXCL10
Systematic review
title A systematic review of circulating IP-10/CXCL10 in patients with Plasmodium infections in relation to disease severity
title_full A systematic review of circulating IP-10/CXCL10 in patients with Plasmodium infections in relation to disease severity
title_fullStr A systematic review of circulating IP-10/CXCL10 in patients with Plasmodium infections in relation to disease severity
title_full_unstemmed A systematic review of circulating IP-10/CXCL10 in patients with Plasmodium infections in relation to disease severity
title_short A systematic review of circulating IP-10/CXCL10 in patients with Plasmodium infections in relation to disease severity
title_sort systematic review of circulating ip 10 cxcl10 in patients with plasmodium infections in relation to disease severity
topic Plasmodium
Malaria
IP-10
CXCL10
Systematic review
url https://doi.org/10.1038/s41598-024-82712-0
work_keys_str_mv AT manaskotepui asystematicreviewofcirculatingip10cxcl10inpatientswithplasmodiuminfectionsinrelationtodiseaseseverity
AT aongartmahittikorn asystematicreviewofcirculatingip10cxcl10inpatientswithplasmodiuminfectionsinrelationtodiseaseseverity
AT frederickramirezmasangkay asystematicreviewofcirculatingip10cxcl10inpatientswithplasmodiuminfectionsinrelationtodiseaseseverity
AT kwuntidauthaisarkotepui asystematicreviewofcirculatingip10cxcl10inpatientswithplasmodiuminfectionsinrelationtodiseaseseverity
AT manaskotepui systematicreviewofcirculatingip10cxcl10inpatientswithplasmodiuminfectionsinrelationtodiseaseseverity
AT aongartmahittikorn systematicreviewofcirculatingip10cxcl10inpatientswithplasmodiuminfectionsinrelationtodiseaseseverity
AT frederickramirezmasangkay systematicreviewofcirculatingip10cxcl10inpatientswithplasmodiuminfectionsinrelationtodiseaseseverity
AT kwuntidauthaisarkotepui systematicreviewofcirculatingip10cxcl10inpatientswithplasmodiuminfectionsinrelationtodiseaseseverity